Frankfurt Stock Exchange

EQS-News: Südzucker AG successfully completes delisting tender offer

Retrieved on: 
Wednesday, March 13, 2024
Internet, Freedom, Growth, Federal republic, Documentation, AG, Frankfurt Stock Exchange, Cryptocurrency

Listing of CropEnergies AG on the Frankfurt Stock Exchange expires at the end of February 28, 2024

Key Points: 
  • Listing of CropEnergies AG on the Frankfurt Stock Exchange expires at the end of February 28, 2024
    Südzucker AG (”Südzucker”) announced on February 21, 2024, the results of the public delisting tender offer in connection with the delisting of CropEnergies AG (“CropEnergies”).
  • Including the CropEnergies shares acquired by Südzucker outside of the delisting tender offer, Südzucker’s shareholding in CropEnergies has increased (from around 69.2 percent) to around 94.2 percent as of today.
  • We will use the freedom gained to implement our growth strategy.”
    This announcement is neither an offer to purchase nor a solicitation of an offer to sell shares of CropEnergies AG nor an offer or recommendation to purchase shares of Südzucker AG.
  • The offer document and further documentation relating to the delisting tender offer is available at www.powerofplants-offer.com.

EQS-News: Results of the Annual General Meeting 2024 for the financial year 2022/23 of BRAIN Biotech AG

Retrieved on: 
Wednesday, March 13, 2024
MBG, Annual general meeting, Architecture, Supervisory board, Gesellschaft mit beschränkter Haftung, IPO, EUR, Frankfurt Stock Exchange, BRAIN, Annual, Speech, Research

Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.

Key Points: 
  • Zwingenberg, Germany, 12 March 2024 – At today´s Annual General Meeting of BRAIN Biotech AG (Frankfurt Stock Exchange / BNN / ISIN DE0005203947 / WKN 5203949), the shareholders approved all items on the agenda with a clear majority.
  • The establishment of silent partnerships between BRAIN Biotech AG and Hessen Kapital I GmbH and MBG H Mittelständische Beteiligungsgesellschaft Hessen mbH - for the financing of innovative research projects at the locations in Hesse - received approval rates of over 99% in each case.
  • 65,99 % of the share capital was represented at the time of the voting.
  • In his speech to shareholders, CEO Adriaan Moelker said: "We now have the architecture, the employees, the technology, the customers and the products to further accelerate our economic success.

EQS-News: AIXTRON: New shares from stock option program with separate ISIN

Retrieved on: 
Wednesday, March 13, 2024
Frankfurt Stock Exchange, Herzogenrath, Annual, Exercise, Supervisory board, Security (finance)

Herzogenrath, March 5, 2024 - AIXTRON SE (FSE: AIXA), a leading manufacturer of deposition equipment for the semiconductor industry, enabled employees to participate in the Company's share capital through stock option programs and, under the terms of the 2012 stock option program, eligible employees can currently exercise stock options at exercise price EUR 13.14.

Key Points: 
  • Herzogenrath, March 5, 2024 - AIXTRON SE (FSE: AIXA), a leading manufacturer of deposition equipment for the semiconductor industry, enabled employees to participate in the Company's share capital through stock option programs and, under the terms of the 2012 stock option program, eligible employees can currently exercise stock options at exercise price EUR 13.14.
  • The so-called "new shares" arising from the exercise of the above-mentioned options will receive a separate ISIN (International Securities Identification Number) and are not entitled to dividends for fiscal year 2023.
  • The new shares will be traded on the Frankfurt Stock Exchange from today under the ISIN DE000A3EX3C9 up to and including the date of the Annual General Meeting on May 15, 2024.
  • In view of the very positive business development in the past fiscal year, AIXTRON plans to pay a dividend again.

EQS-News: MAX Automation withstanding macroeconomic and industry challenges achieves successful financial year 2023 in line with raised forecast

Retrieved on: 
Wednesday, March 13, 2024
Economic development, 2012 Six-red World Championship, NSM, Supervisory board, Note, Growth, EUR, Max Group, Tax, Automation, Annual, Frankfurt Stock Exchange, MAX, Depreciation, Lithium

Overall, the MAX Group generated sales of EUR 443.1 million and EBITDA of EUR 43.2 million in the past financial year, including the discontinued MA micro division.

Key Points: 
  • Overall, the MAX Group generated sales of EUR 443.1 million and EBITDA of EUR 43.2 million in the past financial year, including the discontinued MA micro division.
  • Consolidated order intake of the MAX Group’s continuing operations fell to EUR 341.2 million (12M 2022: EUR 404.8 million) in financial year 2023 due to customers’ reluctance to invest.
  • Sales revenue from the MAX Group’s continuing operations rose by 16.0% to EUR 397.4 million in financial year 2023 (12M 2022: EUR 342.7 million).
  • Detailed explanations on the application of IFRS 5 and the discontinued operations can be found in the Notes to the Annual Financial Report of MAX Automation SE for financial year 2023.

EQS-News: Kontron gains control of Katek SE – mandatory offer follows

Retrieved on: 
Wednesday, March 13, 2024
CFO, Acquisition, Mandate, KTN, Supervisory board, Kątek, Internet of things, Synergy, EUR, History, ODM, Blog, Frankfurt Stock Exchange, Regulated market, WKN, Solar energy, K-OS, Network equipment provider

Linz, 29 February 2024 –Kontron AG, a world’s leading provider of IoT technology, gained control of the listed company KATEK SE via Kontron Acquisition GmbH.

Key Points: 
  • Linz, 29 February 2024 –Kontron AG, a world’s leading provider of IoT technology, gained control of the listed company KATEK SE via Kontron Acquisition GmbH.
  • Following today’s acquisition of control over Katek SE, Kontron Acquisition GmbH will publish a mandatory offer to the shareholders of Katek SE in the coming weeks in accordance with the provisions of the German Securities Acquisition and Takeover Act (Wertpapiererwerbs- und Übernahmegesetz).
  • The bidder intends to issue the mandatory offer as a simultaneous delisting acquisition offer to enable the revocation of the admission of the shares of KATEK SE for trading on the Regulated Market of the Frankfurt Stock Exchange.
  • In addition, Kontron is also working on an exchange offer involving Kontron shares, which will be open to KATEK shareholders as an alternative.

EQS-News: DOUGLAS Group sets price range for its IPO

Retrieved on: 
Wednesday, March 13, 2024
CFO, Jefferies, Supervisory board, Deutsche Bank, Competition Commission, FMCG, GfK, Investment, Research, Management, Growth, Johnson & Johnson, Primary shares, UBS, Sale, Calendar, Beauty, Frankfurt Stock Exchange, IPO, CVC Capital Partners, Federal Financial Supervisory Authority, LBBW, Organization, Economics, Goldman Sachs, RBI, Citigroup, CVC, BNP Paribas, UniCredit, Intesa Sanpaolo, Security (finance)

The price range implies a total market capitalization of between 2.8 billion euro and 3.1 billion euro.

Key Points: 
  • The price range implies a total market capitalization of between 2.8 billion euro and 3.1 billion euro.
  • The German Federal Financial Supervisory Authority (BaFin) approved the securities prospectus for the public offer in Germany and listing of DOUGLAS today.
  • With our strong business model and successful growth strategy, the DOUGLAS Group is optimally positioned in a very attractive market.
  • Through Management Equity Programs, the members of the Executive Board as well as current and former managers of the DOUGLAS Group have indirectly invested in the company.

EQS-News: KPS AG successfully carries out cash capital increase

Retrieved on: 
Wednesday, March 13, 2024
Prospectus, Person, KPS, EUR, WKN, Frankfurt Stock Exchange, AMERICA, Security (finance)

Unterfoehring/Munich, 12 March 2024 – KPS AG (WKN: A1A6V4 / ISIN: DE000A1A6V48), Europe's leading consultancy for digital transformation and process optimisation in retail, has successfully completed the cash capital increase resolved on 7 March 2024.

Key Points: 
  • Unterfoehring/Munich, 12 March 2024 – KPS AG (WKN: A1A6V4 / ISIN: DE000A1A6V48), Europe's leading consultancy for digital transformation and process optimisation in retail, has successfully completed the cash capital increase resolved on 7 March 2024.
  • The capital increase was oversubscribed.
  • A total of 3,741,200 new no-par value registered shares were placed with selected investors as part of a private placement.
  • The gross issue proceeds from the capital increase thus amount to EUR 4,302,380.00.

EQS-News: Evotec and Claris Ventures streamline access to accelerate programmes from Claris's portfolio companies into the clinic

Retrieved on: 
Wednesday, March 13, 2024
IAMA, EVO, MDAX, Safety, DSM-IV codes, Therapy, Pharmacokinetics, Acceleration, IndiGo, Frankfurt Stock Exchange, Partnership, Pharmaceutical industry

Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and biotech venture capital firm Claris Ventures (“Claris”) today announced an acceleration framework to streamline programmes from Claris’s portfolio companies into the clinic through Evotec’s fully integrated platform.

Key Points: 
  • Evotec SE (Frankfurt Stock Exchange: EVT, MDAX/TecDAX, ISIN: DE0005664809; NASDAQ: EVO) and biotech venture capital firm Claris Ventures (“Claris”) today announced an acceleration framework to streamline programmes from Claris’s portfolio companies into the clinic through Evotec’s fully integrated platform.
  • Claris’s portfolio is focused on biotech companies with programmes approaching clinical trials and currently consists of nine biotech companies across Italy, Switzerland, and the UK.
  • Evotec is already supporting Claris’s portfolio company IAMA Therapeutics (“IAMA”), a Genoese Biotech company focused on innovative medicines for brain disorders.
  • Building on this success, the acceleration framework agreement now provides Claris’s other portfolio companies with easy access to Evotec’s full range of integrated services.

EQS-News: FORM NOTIFICATION OF SHARE REPURCHASE PROGRAMME

Retrieved on: 
Wednesday, March 13, 2024
Deutsche Post DHL Group, Buyback, Share repurchase, European, Frankfurt Stock Exchange, EUR, Council, News, European Parliament, Commission, Annual

2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission (as amended or replaced from time to time)

Key Points: 
  • 2 para 1 of the Delegated Regulation (EU) 2016/1052 of the Commission (as amended or replaced from time to time)
    On November 24th, 2023 the Company’s Management Board has resolved to undertake – apart from the share buy programme decided in February 2022 - a further programme of share buybacks (Buyback Programme) of Deutsche Post AG and to offer these shares exclusively those executives who participate in the global share matching plan.
  • Up to 3m shares for a total purchase price (excluding incidental expenses) of up to EUR 150m will be repurchased within the scope of this additional Buyback Programme.
  • The repurchase via the stock exchange will start on March 8th, 2024 and will end on April 19th, 2024 the latest.
  • The Buyback Programme is based on the authorization of the Annual General Meeting of May 4th, 2023, valid until May 3rd, 2028 to launch a share buyback programme in the amount of up to 10% of the Company’s share capital existing at the date the resolution on the share buyback is adopted.

EQS-News: tradias Integrates with Wyden to Expand Institutional Access to the Digital Asset Ecosystem

Retrieved on: 
Wednesday, March 13, 2024
OTC, Partnership, Fintech, Frankfurt Stock Exchange, Treasury, Gesellschaft mit beschränkter Haftung, Cryptocurrency

Zurich/Frankfurt am Main – tradias GmbH, one of the leading European trading houses for cryptocurrencies and digital assets, has announced its strategic integration with Wyden, a premier provider of institutional digital asset trading technology.

Key Points: 
  • Zurich/Frankfurt am Main – tradias GmbH, one of the leading European trading houses for cryptocurrencies and digital assets, has announced its strategic integration with Wyden, a premier provider of institutional digital asset trading technology.
  • This partnership broadens tradias’ reach among institutional clients while adding a new source of deep crypto liquidity to the Wyden platform.
  • By integrating tradias into its institutional digital asset ecosystem, Wyden further expands its network of top-tier liquidity providers that their clients can leverage to trade crypto assets with confidence.
  • “tradias stands out in the digital asset landscape and will enrich the liquidity available to Wyden clients looking to achieve best execution.